Should I buy XPO, Inc. (XPO) stock or is it too late?
⭐ The most reliable of them, either direction: Truist Securities — 68% of its targets hit on this sector (212 calls tested). It aims for $220 (+21 %), call made on October 8, 2026, maturing on October 8, 2027 (6 d ago).
Firm-by-firm track record on XPO, Inc.
| Firm | % right | Gain vs sector | Calls | Aims for |
|---|---|---|---|---|
| BMO Capital | 100 % | +112.8 % | 9 | $245 +35% |
| UBS | 89 % | +67.6 % | 9 | $257 +42% |
| Goldman Sachs | 78 % | +67.2 % | 9 | $167 -8% |
| JP Morgan | 85 % | +66.7 % | 20 | $205 +13% |
| Jefferies | 88 % | +62.9 % | 8 | $275 +52% |
| Citigroup | 88 % | +57.3 % | 17 | $224 +24% |
| Benchmark | 88 % | +53.1 % | 17 | $240 +32% |
| Raymond James | 72 % | +51.0 % | 29 | $225 +24% |
✅ Reasons to believe
- 85% of analysts rate it a buy (Buy consensus, 20 ratings) — a sign of market conviction.
- Median price target $232, i.e. +28% from the current price ($181).
- The most reliable firm on XPO, BMO Capital (100% hit rate, 9 scored calls), targets $245 (call made on June 4, 2026, maturing on June 4, 2027) (+35%) in its most recent call.
⚠️ Reasons to hesitate
- The consensus is not unanimous: of 20 ratings, 2 are neutral and 1 is a sell.
- A 12-month target is not a guaranteed path: the price can fall in the meantime.
- No dividend: your return depends only on price appreciation.
The analyst consensus on XPO
Median target $232 (+28%) · 20 ratings · Buy consensus
⚠️ Information, not investment advice. Past performance does not guarantee future results. Analyst targets on a ~12-month horizon.
Frequently asked questions
Should you invest in XPO, Inc. now?
We won't decide for you. The facts: 85% of analysts rate it a buy, median target $232 (+28%), and BMO Capital (most reliable on XPO, 100%) targets $245. Weigh that against valuation. This is not personalized advice.
Is it too late to invest in XPO, Inc.?
Not according to analysts: the median target ($232) is still +28% above the current price ($181) (most reliable on XPO: BMO Capital, 100%). The real question isn't "too late" but the price-to-value gap and risk. Not advice.
Is XPO, Inc. still worth investing in?
It depends on the gap between the price ($181) and its estimated value: analysts target $232 on median (+28%), with 85% buys (most reliable on XPO: BMO Capital, 100%). Cross-check with their real reliability on XPO and the cautions above. Information, not advice.
What's the main risk in buying XPO?
The consensus is not unanimous: of 20 ratings, 2 are neutral and 1 is a sell.
→ Go deeper: the full XPO, Inc. profile (consensus, analyst reliability, price target, performance).